Literature DB >> 33951667

Neurovascular Interactions in Malaria.

Maiara N Lima1, Rodrigo J R X Freitas1, Beatriz A B R Passos1, Ana Maria G Darze1, Hugo C Castro-Faria-Neto1, Tatiana Maron-Gutierrez1,2.   

Abstract

Malaria is caused by Plasmodium infection and remains a serious public health problem worldwide, despite control efforts. Malaria can progress to severe forms, affecting multiple organs, including the brain causing cerebral malaria (CM). CM is the most severe neurological complication of malaria, and cognitive and behavior deficits are commonly reported in surviving patients. The number of deaths from malaria has been reducing in recent years, and as a consequence, neurological sequelae have been more evident. Neurological damage in malaria might be related to the neuroinflammation, characterized by glia cell activation, neuronal apoptosis and changes in the blood-brain barrier (BBB) integrity. The neurovascular unit (NVU) is responsible for maintaining the homeostasis of the BBB. Endothelial and pericytes cells in the cerebral microvasculature and neural cells, as astrocytes, neurons, and microglia, compose the NVU. The NVU can be disturbed by parasite metabolic products, such as heme and hemozoin, or cytokines that can promote activation of endothelial and glial cells and lead to increased BBB permeability and subsequently neurodegeneration. In this review, we will approach the main changes that happen in the cells of the NVU due to neuroinflammation caused by malaria infection, and elucidate how the systemic pathophysiology is involved in the onset and progression of CM.
© 2021 S. Karger AG, Basel.

Entities:  

Keywords:  Astrocytes; Blood-brain barrier; Endothelial cells; Malaria; Microglia; Neurons

Year:  2021        PMID: 33951667     DOI: 10.1159/000515557

Source DB:  PubMed          Journal:  Neuroimmunomodulation        ISSN: 1021-7401            Impact factor:   2.492


  2 in total

Review 1.  Virus-Induced Membrane Fusion in Neurodegenerative Disorders.

Authors:  Carolina Osorio; Adonis Sfera; Jonathan J Anton; Karina G Thomas; Christina V Andronescu; Erica Li; Rayan W Yahia; Andrea García Avalos; Zisis Kozlakidis
Journal:  Front Cell Infect Microbiol       Date:  2022-03-24       Impact factor: 6.073

2.  Pre-referral intranasal artesunate powder for cerebral malaria: a proof-of-concept study.

Authors:  Anne-Lise Bienvenu; Stephane Picot; Yobouet Ines Kouakou; Aurelien Millet; Elodie Fromentin; Nathalie Hauchard; Gonçalo Farias; Maxime Fieux; Aurelie Coudert; Roukayatou Omorou; Ibrahim Bin Sa'id; Adeline Lavoignat; Guillaume Bonnot
Journal:  Malar J       Date:  2022-10-11       Impact factor: 3.469

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.